Tradestie Institutional Equity Comparison Engine

NRIX vs AURA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NRIX Overall Edge

NRIX Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Nurix Therapeutics, Inc. Common stock (NRIX) driven by superior Valuation, Growth & Margin while AURA counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, NRIX trades at N/M Forward P/E with 41.3% operating margin (+8426.3% YoY revenue) versus AURA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, NRIX sits in BREAKDOWN (4th %ile IV; Dealer Gamma Walls on Pro) against AURA sits in CONSOLIDATION (22nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner NRIX
NRIX N/M vs AURA N/M Fwd P/E
Growth & Margin Winner NRIX
Op Margin 41.3% vs 0.0% ยท YoY +8426.3% vs +0.0%
Momentum & Technical Winner AURA
1Y +20.8% vs +30.4% ยท 52W Pos 18% vs 52%
Options & Structure Winner AURA
BREAKDOWN (4th %ile IV) vs CONSOLIDATION (22nd %ile IV)
NRIX NASDAQ
Nurix Therapeutics, Inc. Common stock
Pharmaceutical Preparations
$15.01
-3.04% 1D
Market Cap $1.7B
1M Return -38.53%
1Y Return +20.76%
Forward P/E N/M
Unified AI Score
52.9 / 100 HOLD
Tech 55.0 Fund 58.0 Flow 64.0 Mom 55.0
AURA NASDAQ
Aura Biosciences, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$7.21
+1.41% 1D
Market Cap $728.6M
1M Return +18.2%
1Y Return +30.38%
Forward P/E N/M
Unified AI Score
28.8 / 100 SELL
Tech 50.0 Fund 39.0 Flow 71.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NRIX +20.76% AURA +30.38% Spread: +9.62 pp (AURA Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
NRIX TTM Op. Margin: 41.3% AURA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NRIX vs AURA. Trailing 12-month operating profitability (NRIX 41.3% vs AURA 0.0%) and valuation multiples (NRIX N/M vs AURA N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NRIX (7) vs AURA (2)
Institutional Metric NRIX AURA Criterion Row Winner
Market Capitalization Scale $1.7B $728.6M Larger Scale NRIX
Trailing P/E Ratio Valuation 6.4x N/M Lower Multiple NRIX
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +8426.3% +0.0% Higher Growth NRIX
Operating Margin (TTM) Profitability 41.3% 0.0% Higher Margin NRIX
Net Profit Margin Profitability 42.0% 0.0% Higher Margin NRIX
Return on Equity (ROE) Capital Efficiency 44.0% -61.7% Higher ROE NRIX
52-Week Range Position Momentum 18% ($12โ€“$28) 52% ($5โ€“$10) Stronger Trend AURA
Beta / 30D Volatility Risk Regime 0.94ฮฒ ยท 141% Vol 0.92ฮฒ ยท 75% Vol Lower Realized Risk AURA
Unified Institutional Score Composite Signal 52.9 / 100 (HOLD) 28.8 / 100 (SELL) Higher Composite NRIX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NRIX vs AURA Buy Guide
NRIX BREAKDOWN
62d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 4th %ile
IV Regime Compressed (<25th %ile)
Live NRIX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
AURA CONSOLIDATION
135d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 22nd %ile
IV Regime Compressed (<25th %ile)
Live AURA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NRIX nor AURA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.